Bio-Rad Laboratories 

$297.43
105
+$3.73+1.27% Monday 21:00

统计

当日最高
297.91
当日最低
290.58
52周高点
358.4
52周低点
211.43
成交量
129,948
平均成交量
189,024
市值
0
市盈率
-
股息率
-
股息
-

即将到来

财报

12Feb预期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
1.16
1.81
2.46
3.11
预期EPS
2.714682
实际EPS
不适用

财务

-71.86%利润率
未盈利
2019
2020
2021
2022
2023
2024
5.13B营收
-3.69B净利润

分析师评级

$357.50平均目标价
最高预估为 375.00。
来自过去6个月内的 2 条评分。这不是投资建议。
买入
50%
持有
50%
卖出
0%

其他人也在关注

此列表基于在 Stock Events 上关注 BIO 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Show more...
首席执行官
Mr. Norman D. Schwartz
员工
7700
国家
US
ISIN
US0905722072

上市

0 Comments

分享你的想法

FAQ

Bio-Rad Laboratories 今天的股价是多少?
BIO 当前价格为 $297.43 USD,过去 24 小时上涨了 +1.27%。在图表上更密切关注 Bio-Rad Laboratories 股价表现。
Bio-Rad Laboratories 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Bio-Rad Laboratories 的股票以代码 BIO 进行交易。
Bio-Rad Laboratories 的股价在上涨吗?
BIO 股票较上周下跌 -0.09%,本月下跌 -2.57%,过去一年 Bio-Rad Laboratories 下跌 -15.77%。
Bio-Rad Laboratories 下一次财报日期是什么时候?
Bio-Rad Laboratories 将于 二月 12, 2026 发布下一次财报。
Bio-Rad Laboratories 上一季度的财报怎么样?
BIO 上季度财报为每股 2.26 USD,预估为 1.95 USD,带来 +15.66% 的意外。下季度预估财报为每股 不适用 USD。
Bio-Rad Laboratories 去年的营收是多少?
Bio-Rad Laboratories 去年的营收为 5.13BUSD。
Bio-Rad Laboratories 去年的净利润是多少?
BIO 去年的净收益为 -3.69BUSD。
Bio-Rad Laboratories 有多少名员工?
截至二月 03, 2026,公司共有7,700名员工。
Bio-Rad Laboratories 属于哪个行业?
Bio-Rad Laboratories从事于Health Care行业。
Bio-Rad Laboratories 何时完成拆股?
Bio-Rad Laboratories 上次拆股发生在 三月 08, 2002,比例为 2:1。
Bio-Rad Laboratories 的总部在哪里?
Bio-Rad Laboratories 的总部位于 US 的 Hercules。